We founded Acorda to bring life-changing therapies to people living with a wide range of nervous system disorders. Through the years, we've stayed true to that mission.
Through our community outreach programs and advocacy support, we provide patient education and resources aimed to improve function in many aspects of life.
LEARN MOREWe are dedicated to changing the future for people with neurological diseases, but we also understand that people want to function better today.
LEARN MOREWhen you’re looking for information about conditions of the nervous system, there are many advocacy organizations and websites that can provide you with information about MS and other neurological conditions, treatment, and research.
LEARN MOREprimarily from Ron (Ron Cohen, CEO). He defined in the beginning what the simple core elements of the culture would be, but as we grow larger, it’s left up to the leaders of individual groups to continue that with the new faces coming in…
You are now leaving the Acorda.com site. By clicking "Ok", you will be leaving this website (sponsored by Acorda Therapeutics, Inc.) to enter an external and entirely independent website.
Acorda.com provides this link as a service and assumes no responsibility for any information presented on external websites.
Acorda has acquired Biotie Therapies. We invite you to explore www.acorda.com to learn more about our company, including our continued development of BIotie clinical programs for tozadenant, SYN120 and BTT1023. Information regarding transfers of value made to healthcare professionals and healthcare organizations in connection with Biotie’s clinical development programs is also available.
The website uses cookies, which are text files placed on your computer. Some of these are essential to the site’s operation while others analyse how visitors use the site. These cookies are set by default but you can disable them or view more information about how they are used here. By clicking on continue you consent to our use of cookies.
